Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry

Clinica Chimica Acta

Volumn 366, Issue 1-2, 2006, Pages 249-256

  Bons, Judith A P ^a   De Boer, Douwe ^a   Van Dieijen Visser, Marja P ^a   Wodzig, Will K W H ^a  

^a NONE

Author keywords

Calibration; Criteria; Protein profiling; Quality control; Reproducibility; Surface enhanced laser desorption ionization time of flight mass spectrometry

Indexed keywords

APOMYOGLOBIN; INSULIN;

ANALYTICAL ERROR; ARTICLE; CALIBRATION; DATA ANALYSIS; INSTRUMENT; PIPETTE; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; SIGNAL NOISE RATIO; STANDARD; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

APOPROTEINS; CALIBRATION; INSULIN; MYOGLOBIN; PROTEINS; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33644664450     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.10.019     Document Type: Article

References (28)

1. I. Petricoin, F. Emanuel, G.B. Mills, E.C. Kohn, and L.A. Liotta Proteomic patterns in serum and identification of ovarian cancer Lancet 360 9327 2002 170 171
2. K.R. Kozak, M.W. Amneus, and S.M. Pusey Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis Proc Natl Acad Sci U S A 100 21 2003 12343 12348
3. Z. Zhang, R.C. Bast Jr., and Y. Yu Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res 64 16 2004 5882 5890
4. B. Ye, D.W. Cramer, and S.J. Skates Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry Clin Cancer Res 9 8 2003 2904 2911
5. A.J. Rai, Z. Zhang, and J. Rosenzweig Proteomic approaches to tumor marker discovery Arch Pathol Lab Med 126 12 2002 1518 1526
6. A. Vlahou, J.O. Schorge, B.W. Gregory, and R.L. Coleman Diagnosis of ovarian cancer using decision tree classification of mass spectral data J Biomed Biotechnol 2003 5 2003 308 314
7. L.L. Banez, P. Prasanna, and L. Sun Diagnostic potential of serum proteomic patterns in prostate cancer J Urol 170 2 Pt 1 2003 442 446
8. B.L. Adam, Y. Qu, and J.W. Davis Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men Cancer Res 62 13 2002 3609 3614
9. E.F. Petricoin III, D.K. Ornstein, and C.P. Paweletz Serum proteomic patterns for detection of prostate cancer J Natl Cancer Inst 94 20 2002 1576 1578
10. Y. Qu, B.L. Adam, and Y. Yasui Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients Clin Chem 48 10 2002 1835 1843
11. J. Li, N. White, and Z. Zhang Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population J Urol 171 5 2004 1782 1787
12. T.A Zhukov, R.A Johanson, A.B. Cantor, R.A. Clark, and M.S. Tockman Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry Lung Cancer 40 3 2003 267 279
13. X.D. Zhu, W.H. Zhang, C.L. Li, Y. Xu, W.J. Liang, and P. Tien New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology World J Gastroenterol 10 16 2004 2327 2329
14. T.C. Poon, A.Y. Hui, and H.L. Chan Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study Clin Chem 51 2 2005 328 335
15. E.P. Diamandis Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 49 8 2003 1272 1275
16. A. Karsan, B.J. Eigl, and S. Flibotte Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis Clin Chem 51 8 2005 1525 1528
17. J.A.P. Bons, K.W.H. Wodzig, and M.P. van Dieijen-Visser Protein profiling as a diagnostic tool in clinical chemistry: a review Clin Chem Lab Med 43 12 2005 1281 1290
18. O.J. Semmes, Z. Feng, and B.L. Adam Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility Clin Chem 51 1 2005 102 112
19. M. Plebani Proteomics: the next revolution in laboratory medicine? Clin Chim Acta 357 2 2005 113 122
20. J.O. Westgard, T. Groth, T. Aronsson, and C.H. de Verdier Combined Shewhart-cusum control chart for improved quality control in clinical chemistry Clin Chem 23 10 1977 1881 1887
21. J.O. Westgard Internal quality control: planning and implementation strategies Ann Clin Biochem 40 Pt 6 2003 593 611
22. C.N. White, D.W. Chan, and Z. Zhang Bioinformatics strategies for proteomic profiling Clin Biochem 37 7 2004 636 641
23. J. Gobom, M. Mueller, V. Egelhofer, D. Theiss, H. Lehrach, and E. Nordhoff A calibration method that simplifies and improves accurate determination of peptide molecular masses by MALDI-TOF MS Anal Chem 74 15 2002 3915 3923
24. J. Koopmann, Z. Zhang, and N. White Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry Clin Cancer Res 10 3 2004 860 868
25. Jock CA, Paulauskis JD, Baker D, Olle E, Bleavins MR, Jonhson KJ, et al. Influence of matrix application timing on spectral reproducibility and quality in SELDI-TOF-MS. Biotechniques 2004;37(1):30-2, 34.
26. Cordingley HC, Roberts SL, Tooke P, Armitage JR, Lane P, Wu W, et al. Multifactorial screening design and analysis of SELDI-TOF ProteinChip array optimization experiments. Biotechniques 2003;34(2):364-5, 8-73.
27. D.A Colantonio, and D.W. Chan The clinical application of proteomics Clin Chim Acta 357 2 2005 151 158
28. M. Aivado, D. Spentzos, and G. Alterovitz Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling Clin Chem Lab Med 43 2 2005 133 140